Renal - Acute
Device Renal
General payments
$1,532,392
Research payments
$310,350
Through program year 2025, $1,532,392 in general payments and $310,350 in research payments were reported against Renal - Acute (Renal).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $648,106 | 1,259 |
| 2025 | Research | $18,000 | 2 |
| 2024 | General | $434,600 | 711 |
| 2024 | Research | $25,192 | 1 |
| 2023 | General | $97,102 | 94 |
| 2022 | General | $31,195 | 57 |
| 2022 | Research | $32,315 | 1 |
| 2021 | General | $7,613 | 35 |
| 2021 | Research | $100,000 | 2 |
| 2020 | General | $86,694 | 61 |
| 2020 | Research | $134,843 | 3 |
| 2019 | General | $227,083 | 81 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,298 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.